内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

JCEM：青春期前肌细胞内脂质沉积与代谢疾病风险相关（EPOCH研究）

2012-04-25 高晓方译 医学论坛网

内分泌代谢儿童肌细胞内脂肪沉积
关注

　　美国学者进行的EPOCH研究表明，在青春期前儿童中，肌细胞内脂质（IMCL）与内脏脂肪沉积有关，肌细胞内脂肪沉积与胰岛素抵抗标志物和心血管疾病风险相关。论文于2011年4月16日在线发表于《临床内分泌学与代谢杂志》（J Clin Endocrinol Metabol）。 　　在青少年和成人中肌细胞内脂质沉积与代谢失调相关，但目前对青春期前肌肉内脂肪沉积尚知之甚少

　　美国学者进行的EPOCH研究表明，在青春期前儿童中，肌细胞内脂质（IMCL）与内脏脂肪沉积有关，肌细胞内脂肪沉积与胰岛素抵抗标志物和心血管疾病风险相关。论文于2011年4月16日在线发表于《临床内分泌学与代谢杂志》（J Clin Endocrinol Metabol）。

　　在青少年和成人中肌细胞内脂质沉积与代谢失调相关，但目前对青春期前肌肉内脂肪沉积尚知之甚少。此项研究以青春期前和青春期早期儿童为受试者，并对IMCL蓄积与内脏脂肪以及胰岛素抵抗标志物和心血管疾病风险的相关性进行了评估。相关数据来自于一项回归性队列研究。构建多元线性回归模型用于数据分析。

　　研究共纳入441例儿童受试者，其中青春期前和青春期早期儿童分别为226和215例。在青春期前儿童中，IMCL和内脏脂肪之间存在显著相关性；对体质指数校正后亦如此。在所有儿童中，IMCL均与甘油三酯/高密度脂蛋白比相关（P=0.002），并且独立于整体肥胖。

　　原始链接：　　

Brumbaugh DE, Crume TL, Nadeau K, Scherzinger A, Dabelea D. Intramyocellular Lipid Is Associated with Visceral Adiposity, Markers of Insulin Resistance, and Cardiovascular Risk in Prepubertal Children: The EPOCH Study.J Clin Endocrinol Metab. 2012 Apr 16.
 


    

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-06-29 smallant2015

    #JCEM#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-08-29 rebeccajiejie

    #脂质沉积#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-08-05 okhuali

    #EPOCH#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-05-17 achengzhao

    #JCE#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-04-27 zhzhxiang

    #青春期#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-04-27 windight

    #代谢疾病#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1777377, encodeId=da941e773775a, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Fri Jun 29 22:16:00 CST 2012, time=2012-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1810291, encodeId=aedc181029133, content=<a href='/topic/show?id=cf78844426e' target=_blank style='color:#2F92EE;'>#脂质沉积#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84442, encryptionId=cf78844426e, topicName=脂质沉积)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1cc90, createdName=rebeccajiejie, createdTime=Wed Aug 29 17:16:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643077, encodeId=dacc16430e7ef, content=<a href='/topic/show?id=7d8b689351' target=_blank style='color:#2F92EE;'>#EPOCH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6893, encryptionId=7d8b689351, topicName=EPOCH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=113323104213, createdName=okhuali, createdTime=Sun Aug 05 23:16:00 CST 2012, time=2012-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062750, encodeId=1cae2062e50f9, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Thu May 17 05:16:00 CST 2012, time=2012-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275479, encodeId=f2cb12e54792d, content=<a href='/topic/show?id=5d0299032b9' target=_blank style='color:#2F92EE;'>#青春期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99032, encryptionId=5d0299032b9, topicName=青春期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401982, encodeId=1db014019829e, content=<a href='/topic/show?id=193025463d8' target=_blank style='color:#2F92EE;'>#代谢疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25463, encryptionId=193025463d8, topicName=代谢疾病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/F9591315BE4091482318EFFCD39C9D08/100, createdBy=bf9f2374681, createdName=windight, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472910, encodeId=4c7214e2910b6, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Fri Apr 27 02:16:00 CST 2012, time=2012-04-27, status=1, ipAttribution=)]
    2012-04-27 花花1368

    #疾病风险#

    0

相关资讯

2型糖尿病合并血脂异常共识

　　近日，中华医学会第十次全国内分泌学学术会议在古城苏州召开。来自哈尔滨医科大学附属第二医院的李强教授介绍了中国2型糖尿病合并血脂异常防治的专家共识（征求意见稿）。 　　2型糖尿病患者的血脂谱以混合型血脂紊乱多见，甘油三酯（TG）高、高密度脂蛋白胆固醇（HDL-C）低、小而密低密度脂蛋白胆固醇（sLDL-C）水平高，apoB、apoC Ⅲ 水平升高。 　　共识认为，2型糖尿病患者在被确诊时就应

2011年中国内分泌领域十大关键进展汇总

我国孕妇应常规筛查甲状腺功能，否则高达八成将被漏诊 　　中国医科大学附属第一医院 滕卫平 　　仅对高危人群进行筛查是远远不够的，国外其他研究也都得到类似结果。 　　对于我国人群而言，如果仅筛查高危妊娠女性，将会遗漏81.6%甲状腺功能减退患者和80.6%甲状腺功能亢进症者。就具体指标，目前多数人推荐的TSH并不理想，应把TSH 、FT4、TPOAb作为早期妊娠妇女筛查项目。 　　中国医科大学附属

甲状腺药物安全性评价

　　2011年8月19日，在在第十次全国内分泌学学术会议上，上海第二军医大学附属长征医院石勇铨教授报告了甲状腺药物的安全性评价问题。 　　石教授指出，目前临床常用的甲状腺药物是硫胺类化合物，主要包括他巴唑、丙基硫氧嘧啶（PTU）等，其主要作用机制是抑制甲状腺激素的合成。 　　常见的药物不良反应 　　PTU和他巴唑可引起多达13%的患者出现皮肤瘙痒、皮疹、荨麻疹、关节痛、关节炎、发热、味觉异常

AACE绝经后骨质疏松诊治指南

　　骨质疏松是一种日益增多的严重性公共健康问题，并且可对医疗、社会和经济产生影响。此项指南由美国临床内分泌医师学会（AACE）制定[Endocr Pract. 2010；16（Suppl 3）]，并且希望以此降低骨质疏松相关性骨折风险，进而改善骨质疏松患者的生活质量。此项指南采用了最佳证据，并将疾病的经济影响以及绝经后骨质疏松女性的有效评估和治疗需求纳入考量范围。此项

内分泌疾病的CT和MR诊断

　　近日，在第十次全国内分泌学学术会议上，上海交通大学医学院附属瑞金医院方文强教授报告了内分泌疾病的CT和磁共振（MR）诊断要点。 　　方教授指出，正确诊断是有效治疗的前提。随着超声、CT、MR、核医学和介入放射学等医学影像技术的飞速发展，医学影像学在内分泌疾病的诊断中应用越来越广泛。 　　垂体影像学检查的目的在于确定垂体腺瘤的位置和大小。由于多数垂体瘤为微腺瘤，既往蝶鞍摄片很少发现垂体异常，

全球糖尿病患者近3.5亿

全球慢性疾病代谢性危险因素负担合作组(GBMRFCDCG)根据近30年来空腹血糖水平的变化趋势，估计全世界现有约3.47亿成年人罹患糖尿病。该研究发表在《柳叶刀》6月25日在线版上(the Lancet. doi:10.1016/S0140-6736(11)60679-X)。 研究者收集、分析了199个国家和地区29年来的健康调查和流行病学研究数据，选择平均空腹血糖作为主要的血糖指标，其他血糖指